What is Nilotinib Capsule?

Nilotinib Capsules are targeted anticancer medications used primarily in the treatment of chronic myeloid leukemia (CML), a type of blood cancer that affects white blood cells. It belongs to a class of medicines known as tyrosine kinase inhibitors (TKIs), which work by blocking abnormal proteins responsible for the uncontrolled growth of cancer cells.

Nilotinib is commonly prescribed for patients who are newly diagnosed with CML or those who are resistant or intolerant to other treatments, helping to control the disease effectively.

Description

Nilotinib Capsules are oral chemotherapy drugs available in strengths of 150 mg and 200 mg, allowing flexibility in dosing based on individual patient needs. This medication specifically targets the BCR-ABL protein, which plays a key role in the development of CML.

It is widely used as a long-term treatment option to manage leukemia and maintain disease remission, offering a more targeted and precise approach compared to conventional chemotherapy.

Uses of Nilotinib Capsules

• Treatment of newly diagnosed chronic myeloid leukemia (CML)
• Treatment of CML in chronic phase and accelerated phase
• Used in patients resistant or intolerant to prior therapies
• Helps control abnormal white blood cell production

Indications

• Indicated for adult patients with Philadelphia chromosome-positive (Ph+) CML
• Used in both newly diagnosed and previously treated patients
• Prescribed under strict supervision of an oncologist
• Dosage depends on disease condition and patient response

Benefits

• Targets cancer cells specifically, reducing damage to normal cells
• Helps achieve and maintain remission in CML patients
• Slows disease progression effectively
• Oral capsule form allows convenient administration
• Improves long-term survival outcomes

Drug Interactions

Nilotinib may interact with several medications, including:

• Ketoconazole, Itraconazole
• Clarithromycin, Erythromycin
• Rifampin, Phenytoin
• Omeprazole and other acid-reducing agents
• Antiarrhythmic drugs

Avoid grapefruit and grapefruit juice during treatment. Always inform your doctor about all medications and supplements you are taking.

How Nilotinib Works

• Inhibits the BCR-ABL tyrosine kinase enzyme
• Blocks signals that promote cancer cell growth
• Prevents proliferation of abnormal white blood cells
• Helps restore normal blood cell production

Warnings & Precautions

• May cause heart rhythm problems (QT prolongation)
• Regular ECG and blood monitoring are required
• Take on an empty stomach (avoid food 2 hours before and 1 hour after dose)
• Use cautiously in patients with liver or heart conditions
• Not recommended during pregnancy or breastfeeding

General Instructions

• Take capsules exactly as prescribed by your doctor
• Swallow whole with water; do not crush or chew
• Maintain proper timing related to meals
• Do not skip doses or stop treatment without medical advice
• Follow regular monitoring schedules

Storage Information

• Store in a cool, dry place away from moisture and heat
• Keep in original packaging
• Keep out of reach of children and pets
• Do not use expired medication

Special Advice for Patients

• Attend regular blood tests and ECG monitoring
• Avoid grapefruit products during treatment
• Maintain a healthy diet and lifestyle
• Report symptoms like irregular heartbeat, dizziness, or weakness immediately

Why Choose Onco India International?

At Onco India International, we are committed to delivering high-quality, affordable, and globally trusted oncology medicines. Our Nilotinib Capsules are manufactured under strict quality standards to ensure safety, effectiveness, and reliability in cancer treatment.